Company Filing History:
Years Active: 2015-2020
Title: Roy M Vijesurier: Innovator in Hepatitis B Research
Introduction
Roy M Vijesurier is a notable inventor based in Des Plaines, IL (US). He has made significant contributions to the field of medical research, particularly in the area of Hepatitis B virus detection and analysis. With a total of 2 patents to his name, Vijesurier's work has the potential to impact public health positively.
Latest Patents
Vijesurier's latest patents focus on a Hepatitis B virus typing and resistance assay. This invention provides methods, kits, and oligonucleotides for detecting and analyzing the nucleotide sequence of a reverse transcriptase (RT) region of the polymerase (Pol) gene of Hepatitis B Virus (HBV). In certain embodiments, a target RT region is amplified and subjected to DNA sequencing. The sequence obtained is compared to one or more DNA sequences characteristic of an HBV genotype or serotype, and/or one or more DNA sequences characteristic of an HBV mutation that confers resistance to a drug or vaccine. This process helps determine the HBV genotype or serotype of the amplified product and/or the presence or absence of one or more DNA sequences characteristic of an HBV mutation that confers resistance to a drug or vaccine.
Career Highlights
Vijesurier is currently associated with Abbott Molecular Inc., a company known for its innovative solutions in molecular diagnostics. His work at Abbott has allowed him to contribute to advancements in medical technology and diagnostics.
Collaborations
Some of his notable coworkers include Gregor W Leckie and Reuben J Ofsaiof. Their collaboration has likely fostered an environment of innovation and shared expertise in their research endeavors.
Conclusion
Roy M Vijesurier's contributions to Hepatitis B research through his patents and work at Abbott Molecular Inc. highlight his role as an important figure in the field of medical innovation. His inventions have the potential to enhance the understanding and treatment of Hepatitis B, ultimately benefiting public health.